Themes ETFs Reintroduces Humanoid Robotics ETF on Nasdaq (Ticker: BOTT)
Humanoid Robotics ETF Launch: Themes ETFs has re-launched the Humanoid Robotics ETF (BOTT), providing low-cost access to companies involved in developing human-like robots and AI technologies, with an expense ratio of 0.35%.
Index Tracking: BOTT will track the Solactive Global Humanoid Robotics Index NTR, which encompasses a wide range of companies in the humanoid robotics ecosystem, including service robots, industrial automation, and assistive technologies.
Investment Strategy: The ETF aims to offer investors targeted exposure to sectors poised for growth in robotics and automation, reflecting the rapid advancements in technology and investor interest.
Company Background: Themes ETFs was co-founded by Jose Gonzalez-Navarro, Dobromir Kamburov, and Tracy Grant, and seeks to provide thematic investment opportunities across various cutting-edge industries.
Trade with 70% Backtested Accuracy
Analyst Views on BOTT
No data
About the author
Themes ETFs Reintroduces Humanoid Robotics ETF on Nasdaq (Ticker: BOTT)
Humanoid Robotics ETF Launch: Themes ETFs has re-launched the Humanoid Robotics ETF (BOTT), providing low-cost access to companies involved in developing human-like robots and AI technologies, with an expense ratio of 0.35%.
Index Tracking: BOTT will track the Solactive Global Humanoid Robotics Index NTR, which encompasses a wide range of companies in the humanoid robotics ecosystem, including service robots, industrial automation, and assistive technologies.
Investment Strategy: The ETF aims to offer investors targeted exposure to sectors poised for growth in robotics and automation, reflecting the rapid advancements in technology and investor interest.
Company Background: Themes ETFs was co-founded by Jose Gonzalez-Navarro, Dobromir Kamburov, and Tracy Grant, and seeks to provide thematic investment opportunities across various cutting-edge industries.
Fortive Q4: EPS Tops, Revenue Misses, CEO Confident In 2025 Recovery
Fourth Quarter Results: Fortive Corporation reported a 2% year-over-year revenue growth to $1.620 billion, which fell short of expectations, while adjusted EPS of $1.17 exceeded consensus estimates. The company saw strong performance in its Intelligent Operating Solutions and Advanced Healthcare Solutions segments.
Future Outlook: For FY25, Fortive anticipates revenue between $6.23 billion and $6.35 billion, lower than the consensus estimate, with expected first-quarter revenue also below projections. The stock is currently down 3.57% in premarket trading.
Themes ETFs Reintroduces Humanoid Robotics ETF on Nasdaq (Ticker: BOTT)
Humanoid Robotics ETF Launch: Themes ETFs has re-launched the Humanoid Robotics ETF (BOTT), providing low-cost access to companies involved in developing human-like robots and AI technologies, with an expense ratio of 0.35%.
Index Tracking: BOTT will track the Solactive Global Humanoid Robotics Index NTR, which encompasses a wide range of companies in the humanoid robotics ecosystem, including service robots, industrial automation, and assistive technologies.
Investment Strategy: The ETF aims to offer investors targeted exposure to sectors poised for growth in robotics and automation, reflecting the rapid advancements in technology and investor interest.
Company Background: Themes ETFs was co-founded by Jose Gonzalez-Navarro, Dobromir Kamburov, and Tracy Grant, and seeks to provide thematic investment opportunities across various cutting-edge industries.
Fortive Q4: EPS Tops, Revenue Misses, CEO Confident In 2025 Recovery
Fourth Quarter Results: Fortive Corporation reported a 2% year-over-year revenue growth to $1.620 billion, which fell short of expectations, while adjusted EPS of $1.17 exceeded consensus estimates. The company saw strong performance in its Intelligent Operating Solutions and Advanced Healthcare Solutions segments.
Future Outlook: For FY25, Fortive anticipates revenue between $6.23 billion and $6.35 billion, lower than the consensus estimate, with expected first-quarter revenue also below projections. The stock is currently down 3.57% in premarket trading.
